Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases

NCT07644754 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Tuebingen

Collaborators